SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten OSCR Q1 2026 Earnings Massive EPS Beat Highlights Insurers Profitability TurnStock Dips Despite Strong Results Ernexa Therapeutics Inc ERNA Q3 2023 Earnings Narrowing Losses Amidst Pipeline Progress GREEL Q1 2025 Earnings Narrower Loss Surpasses Estimates as Senior Notes Remain Stable PSA Q1 2026 Earnings EPS Surpasses Estimates by 124 as Occupancy and Expense Control Drive Results LivaNova LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Amid Modest Stock Decline